Hybrid Nanoparticles in Imaging and Therapy of Prostate*

混合纳米颗粒在前列腺成像和治疗中的应用*

• 批准号: 7280361
• 负责人: Kattesh V Katti
• 金额: $ 58.77万
• 依托单位: UNIVERSITY OF MISSOURI-COLUMBIA
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-09-29 至 2010-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7280361
• 关键词: AA Spectrophotometry; Address; Affinity; Animal Model; Animals; Arts; Attention; Binding; Biochemical; Biodistribution; Biological; Biological Sciences; Bombesin; Bombesin Receptor; Cancer Center; Carbohydrates; Cell surface; Cells; Characteristics; Chemicals; Chemistry; Computers; Condition; Core Facility; Coupled; Detection; Development; Diagnosis; Diagnostic; Dimensions; Disease; Dose; Drug Kinetics; Education; Endocytosis; Engineering; Enhancers; Evaluation; Exhibits; Family suidae; Functional Imaging; Future; GRP gene; Generations; Goals; Gold; Gum Arabic; Human; Human Biology; Hybrids; Image; Image Enhancement; Imaging Techniques; Implant; In Situ; In Vitro; Interdisciplinary Study; Investigation; Isotopes; Knowledge; Label; Lead; Libraries; Liquid substance; Localized; Malignant Neoplasms; Malignant neoplasm of prostate; Mass Spectrum Analysis; Measurement; Medicine; Membrane; Metals; Methods; Missouri; Modality; Modeling; Modification; Molecular; Mus; Nanotechnology; Nature; Neutron Activation Analysis; Organ; Organ Size; Pattern; Peptides; Personal Satisfaction; Phase; Physiology; Plasma; Principal Investigator; Process; Production; Program Development; Property; Prostate; Prostate Cancer therapy; Prostatic Neoplasms; Proteins; Protocols documentation; Radiation therapy; Radioactive; Reaction; Research; Research Infrastructure; Research Personnel; Resources; Roentgen Rays; SCID Mice; Science; Sepharose; Site; Specificity; Staging; Starch; Study models; Sum; Surface; Sus scrofa; System; Techniques; Testing; Theoretical model; Therapeutic; Therapeutic Agents; Therapeutic Human Experimentation; Tissues; Toxicology; Tracer; Transmission Electron Microscopy; Treatment Efficacy; Tumor Specific Peptide; Ultrasonography; Universities; Veterinary Medicine; Work; X-Ray Computed Tomography; Xenograft procedure; absorption; attenuation; base; biomaterial compatibility; cancer cell; cancer type; college; design; improved; in vivo; innovation; interest; knowledge base; lung small cell carcinoma; medical schools; models and simulation; molecular imaging; multidisciplinary; nanomedicine; nanoparticle; nanoparticulate; nanoscale; nanoscience; nanosized; peptide analog; phantom model; programs; radiochemical; receptor; response; sensor; simulation; size; tomography; tumor; tumor xenograft; uptake; vector

DESCRIPTION (provided by applicant): The University of Missouri (MU) Cancer Nanotechnology Platform (CNP) is the culmination of long-standing interdisciplinary partnerships in departments within the School of Medicine, the College of Arts and Science, the College of Veterinary Medicine, the Ellis Fischel Cancer Center, the Missouri University Research Reactor and the College of Engineering. Our CNP's overarching goal focuses on developing hybrid gold nanoparticle-based molecular imaging agents and targeted therapeutic agents that are effective in the diagnosis and treatment of prostate cancer. The specific objectives of our CNP include the following: (i) Synthesize and use a library of gold nanoparticles (AuNPs) for conjugation with prostate tumor-specific bombesin peptides. Investigate the photophysical properties, dispersity, and size-dimension measurements on these gold nanoparticles. (ii) Investigate biolocalization, pharmacokinetics and in vivo profiles of AuNPs stabilized with starch, agarose, and arabinagalactan protein (gum Arabic) in pigs. We will optimize analytical protocols, using techniques of neutron activation analysis (NAA), atomic absorption and radiochemical analysis using Au-198 nanoparticulate tracer, for the accurate estimation of AuNPs/gold metal in tissues and biological fluids, (iii) Develop new theoretical models, computations and simulations for the interaction of AuNPs with cells, (iv) Investigate the utility of AuNPs and bombesin-conjugated hybrid AuNPs as image enhancers in computed tomographic (CT) and ultrasound (US) imaging of prostate tumors in SCID mice implanted with human prostate cancer xenografts and with experimental modeling, simulations and studies on anthropomorphic phantom models of prostate cancer, (v) Optimize production of nanoparticulate a-emitting Au-198/199 and their utility for designing and developing tumor-specific Au-198/199-nanoparticlelabeled bombesin peptides for prostate tumor therapy. These studies will validate that multiple atoms of fiemitting Au-198 isotope, characteristic of nanoparticulate gold, will deliver significantly higher therapeutic payload to tumor sites than any conventional therapy. The MU Nanoparticles Production Core Facility will serve as a research and production resource for the unhindered supply of AuNPs to all investigators within the CNP program. The CNP provides unique opportunities for professionals from diverse academic backgrounds to be involved in collaborative scientific interactions that further our interdisciplinary research, education and product development program. We will apply principles of nanoscience and nanotechnology to develop innovative molecular imaging and therapeutic approaches to combat prostate cancer.

描述（由申请人提供）： 该密苏里州（MU）癌症纳米技术平台（CNP）的大学是长期跨学科的合作伙伴关系在医学院，艺术和科学学院，兽医学院，埃利斯·菲舍尔癌症中心，密苏里州大学研究反应堆和工程学院内的部门的高潮。我们CNP的首要目标是开发基于混合金纳米颗粒的分子成像剂和靶向治疗剂，这些药物在前列腺癌的诊断和治疗中是有效的。我们的CNP的具体目标包括以下内容：（i）合成并使用金纳米颗粒（AuNP）库与前列腺肿瘤特异性蛙皮素肽缀合。研究这些金纳米颗粒的物理性质、分散性和尺寸-尺寸测量。(ii)研究生物定位，药代动力学和在猪体内与淀粉，琼脂糖和阿拉伯半乳聚糖蛋白（阿拉伯树胶）稳定的金纳米粒子的概况。我们将优化分析方案，使用中子活化分析（NAA），原子吸收和放射化学分析技术，使用Au-198纳米颗粒示踪剂，用于准确估计组织和生物流体中的AuNP/金金属，（iii）开发新的理论模型，计算和模拟AuNP与细胞的相互作用，（iv）研究AuNP和蛙皮素缀合的杂合AuNP作为图像增强剂在植入人前列腺癌异种移植物的SCID小鼠中的前列腺肿瘤的计算机断层摄影（CT）和超声（US）成像中的效用，并进行实验建模，对前列腺癌的拟人模型的模拟和研究，（v）优化纳米颗粒α-发射Au-198/199的生产及其用于设计和开发用于前列腺肿瘤治疗的肿瘤特异性Au-198/199-纳米颗粒标记的蛙皮素肽的效用。这些研究将验证场发射Au-198同位素的多个原子（纳米颗粒金的特征）将比任何常规疗法向肿瘤部位递送显著更高的治疗有效载荷。MU纳米颗粒生产核心设施将作为研究和生产资源，为CNP计划内的所有研究人员提供不受阻碍的AuNP。 CNP为来自不同学术背景的专业人士提供了独特的机会，参与协作科学互动，促进我们的跨学科研究，教育和产品开发计划。我们将应用纳米科学和纳米技术的原则，开发创新的分子成像和治疗方法，以打击前列腺癌。